Fox Run Management, L.L.C. Karyopharm Therapeutics Inc. Transaction History

Fox Run Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$2.48 - $5.93 $71,481 - $170,920	28,823 New	28,823 $97,000
Q1 2022 May 10, 2022	SELL	$5.91 - $14.38 $91,268 - $222,070	-15,443 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$5.21 - $8.61 $80,458 - $132,964	15,443 New	15,443 $99,000
Q1 2019 Oct 17, 2019	SELL	$4.12 - $10.25 $66,818 - $166,234	-16,218 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$8.2 - $16.95 $4,936 - $10,203	602 Added 3.86%	16,218 $152,000
Q3 2018 Oct 05, 2018	BUY	$17.03 - $21.18 $265,940 - $330,746	15,616 New	15,616 $266,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.